Archives
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-10-01
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat-derived IgG in ICC/IF, frozen or paraffin IHC, flow cytometry, and fluorescence-compatible ELISA workflows. It should be used with validated goat IgG primary antibodies, not non-goat primaries or unvalidated assay formats.
-
Betaine Hydrochloride in Inflammation Assay Design
2026-09-30
Betaine hydrochloride can improve assay standardization when its ionic, solvent, and storage properties are treated as experimental variables. This article translates a recent oridonin–esophageal cancer study into a rigorous framework for metabolic enzyme, protease, cell culture, and molecular biology workflows without confusing assay support with therapeutic activity.
-
Multiomics of Crossbreeding and Sex in Xingguo Gray Goose
2026-09-30
The reference study combines growth and carcass phenotyping with RNA-seq and untargeted metabolomics to separate crossbreeding and sex effects in Xingguo gray geese. Its integrated analysis links production traits with muscle-development and lipid-metabolism signals, providing a framework for interpreting heterosis in meat-oriented goose production.
-
Fluorescein TSA Fluorescence System Kit Workflow
2026-09-29
Turn weak protein and nucleic-acid signals into spatially resolved fluorescence in fixed cells and tissues. This guide pairs the Fluorescein TSA Fluorescence System Kit with practical IHC, ICC, and ISH workflows, using the miR-3180–SCD1–CD36 HCC study as a model for assay planning and validation.
-
Polyethylenimine Linear: PEI MW 40,000 Workflow
2026-09-29
Build a reproducible PEI transfection workflow for mechanistic cell studies, from HEK-293 reporter assays to chondrocyte models of osteoarthritis. This guide connects practical DNA delivery with the Piezo1–HBB metabolic axis while clearly separating validated in vitro use from exploratory nanoparticle translation.
-
SW033291: From PGE2 Control to Tissue Repair
2026-09-28
SW033291 is a 15-PGDH inhibitor for dissecting how prostaglandin E2 elevation influences hematopoiesis and tissue repair. This article presents an evidence-chain framework that connects enzyme potency with cellular, regenerative, and functional readouts.
-
Late-Stage Mechanics of Clathrin-Mediated Endocytosis
2026-09-28
Using multidimensional single-particle tracking, Wu and colleagues map rotational motions of clathrin-coated pits during late-stage endocytosis in living cells. Their findings distinguish a common dynamin-dependent in-plane twist from an actin-associated out-of-plane “swing,” suggesting that productive membrane remodeling can follow more than one mechanical route.
-
Patient-Derived Gastric Cancer Assembloids
2026-09-27
Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal cell populations, capturing features that are less evident in epithelial-only cultures. The model showed stromal-associated changes in gene expression and drug sensitivity, supporting its use for studying tumor–stroma interactions while underscoring that organoid drug responses may not predict assembloid responses.
-
1-Phenyl-2-Pentanol and Hepatic Stellate Cell Fibrosis
2026-09-26
A 2024 study examined 1-phenyl-2-pentanol, a compound identified from Moringa oleifera leaves, in TGF-β1-stimulated human hepatic stellate cells. The findings connect reduced fibrosis-associated markers with changes in Wnt/β-catenin signaling, while leaving the direct molecular target and in vivo relevance open for further study.
-
CUDC-907: In Vitro Workflow and QC Guide
2026-09-25
CUDC-907 is a dual PI3K and HDAC inhibitor for in vitro studies that need to examine pathway signaling alongside histone acetylation, cell-cycle behavior, or apoptosis. This guide translates the product dossier into practical setup and QC steps; it is for scientific research only, not diagnostic, clinical, or therapeutic use.
-
MK-571 (L-660,711): Evidence & Research Use
2026-09-25
MK-571, also called L-660,711, is a competitive cysteinyl leukotriene receptor 1 antagonist used in leukotriene-mediated inflammation research. Its reported receptor pharmacology and separate MRP1-inhibitory activity make target-specific controls essential when interpreting airway or transporter experiments.
-
MK-8745: From Aurora A Biology to Assay Logic
2026-09-24
Explore how MK-8745, a potent Aurora A inhibitor, can help distinguish target expression from functional dependency in cancer models. A retinoblastoma study offers a practical framework for selecting models and interpreting cell-cycle, apoptosis, and tumor-response data.
-
Niclosamide: From Target Claims to Assay Logic
2026-09-24
Niclosamide is a STAT3-pathway research compound, but interpreting its effects requires more than measuring a single endpoint. This article connects its reported cellular activity to a distinct lesson from a snail-control study: build experiments around dose, exposure time, orthogonal readouts, and explicit evidence boundaries.
-
How Signaling Relates to Preputial Development
2026-09-23
A comparative study links later preputial development and open urethral-groove formation in guinea pigs with species differences in Shh and Fgf expression. Organ-culture perturbations add experimental context, while the findings remain limited to embryonic mouse and guinea-pig models.
-
FAK Inhibitor 14: Applied Research Workflows
2026-09-23
FAK Inhibitor 14 provides a practical chemical approach for testing how focal adhesion kinase controls adhesion, migration, and EMT-associated phenotypes. This workflow-oriented guide connects compound handling with cholesterol-resistant ovarian cancer models, quantitative pathway assays, and troubleshooting strategies for reproducible cancer biology research.